GlassScriptPhysician profile
Luis H Arroyo
NPI 1811965650
$1,404.71
in general payments reported to CMS, 2019-2025
13 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $170 · 2022: $145 · 2023: $575 · 2024: $205 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $288.92 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Boston Scientific Corporation | $253.36 | 2019-2025 | Avvigo Guidance System, General - Therapies, Rotablator Rotational Atherectomy System Console Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $149.18 | 2019-2023 | Lifevest |
| Itamar Medical INC | $145.87 | 2023 | Watchpatone |
| Alnylam Pharmaceuticals INC. | $125.00 | 2022 | |
| Cvrx, INC. | $121.96 | 2023 | Barostim Neo System |
| Medtronic Vascular, INC. | $101.89 | 2020 | |
| Abiomed | $90.74 | 2023-2024 | Impella |
| Pfizer INC. | $38.45 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $24.79 | 2025 | |
| Janssen Pharmaceuticals, INC | $22.44 | 2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $22.21 | 2025 | Assure Wcd |
| Nuwellis, INC. | $19.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Arroyo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.